Trials indicate that screening women between 40 and 49 with mammography res
ults in a clear mortality benefit. Whether this is worth the side-effects a
nd financial cost is a matter of judgement. Some national health authoritie
s and several other bodies consider the balance favourable enough to recomm
end general screening for this age group. (C) 2000 Harcourt Publishers Ltd.